Enanta Pharmaceuticals is a clinical stage biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs for viral infections and immunological diseases. Enanta’s research and development efforts include programs in the following disease areas: respiratory syncytial virus (RSV), SARS-CoV-2 (C0VID-19) and hepatitis B Virus (HBV) and chronic spontaneous urticaria (CSU).

Learn More »


Data Provided by Refinitiv. Minimum 15 minutes delayed.

Recent Press Releases

May 29, 2024
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
May 7, 2024
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference

Upcoming Events

More events are coming soon.